Cytosurge appoints Dr. Magid Haddouchi as Chief Commercial Officer to drive global expansion. With over 15 years of experience, he joins as the company engages in key 2025 events, including AACR (USA), SPMConnect (USA), and ISSCR (Hong Kong). Dr. Haddouchi will focus on expanding the reach of FluidFM technology in single-cell research and precision genome editing, enhancing customer engagement, an